ѻý

Any Exercise a Mood Booster; MDMA Prescribed Down Under; Climate Change Anxiety Real

<ѻý class="mpt-content-deck">— News and commentary from the psychiatry world
MedpageToday
Illustration of a brain shaped maze.

Even doing just small amounts of exercise, below the current recommendations, were in older adults. (JAMA Network Open)

A once-daily investigational stimulant -- designed to deliver three releases of medication in one tablet -- demonstrated "a meaningful trend in improving ADHD symptoms" in a phase III adult trial, said developer Cingulate.

A world first: (aka Ecstasy or Molly) for individuals with post-traumatic stress disorder. (Washington Post)

People with depression and anxiety were more likely to self-report in a retrospective study. (Ear, Nose & Throat Journal)

Using in adolescence wasn't linked with an increased risk for illicit stimulant use in early adulthood, confirming findings from a similar study last week. (JAMA Network Open)

There's no consensus about , experts maintained. (STAT)

Mental health respite facilities helped to in some states. (KFF Health News)

is a "healthy and empathetic" response, psychologists explained. (Science Alert)

During the COVID-19 pandemic, a third of psychiatrists in Beijing said they were experiencing . (BMC Psychiatry)

Meanwhile, U.S. publicly insured youth were over two times more likely to during the pandemic compared with pre-pandemic times and were 64% less likely to be discharged to inpatient psychiatric care. (JAMA Network Open)

Depression may be a distinct condition, fMRI data suggested. (Science Translational Medicine)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.